Literature DB >> 25878146

Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes.

Mark Robertson-Tessi1, Robert J Gillies2, Robert A Gatenby3, Alexander R A Anderson4.   

Abstract

Histopathologic knowledge that extensive heterogeneity exists between and within tumors has been confirmed and deepened recently by molecular studies. However, the impact of tumor heterogeneity on prognosis and treatment remains as poorly understood as ever. Using a hybrid multiscale mathematical model of tumor growth in vascularized tissue, we investigated the selection pressures exerted by spatial and temporal variations in tumor microenvironment and the resulting phenotypic adaptations. A key component of this model is normal and tumor metabolism and its interaction with microenvironmental factors. The metabolic phenotype of tumor cells is plastic, and microenvironmental selection leads to increased tumor glycolysis and decreased pH. Once this phenotype emerges, the tumor dramatically changes its behavior due to acid-mediated invasion, an effect that depends on both variations in the tumor cell phenotypes and their spatial distribution within the tumor. In early stages of growth, tumors are stratified, with the most aggressive cells developing within the interior of the tumor. These cells then grow to the edge of the tumor and invade into the normal tissue using acidosis. Simulations suggest that diffusible cytotoxic treatments, such as chemotherapy, may increase the metabolic aggressiveness of a tumor due to drug-mediated selection. Chemotherapy removes the metabolic stratification of the tumor and allows more aggressive cells to grow toward blood vessels and normal tissue. Antiangiogenic therapy also selects for aggressive phenotypes due to degradation of the tumor microenvironment, ultimately resulting in a more invasive tumor. In contrast, pH buffer therapy slows down the development of aggressive tumors, but only if administered when the tumor is still stratified. Overall, findings from this model highlight the risks of cytotoxic and antiangiogenic treatments in the context of tumor heterogeneity resulting from a selection for more aggressive behaviors. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25878146      PMCID: PMC4421891          DOI: 10.1158/0008-5472.CAN-14-1428

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Mathematical modelling of avascular-tumour growth. II: Modelling growth saturation.

Authors:  J P Ward; J R King
Journal:  IMA J Math Appl Med Biol       Date:  1999-06

2.  A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis.

Authors:  Amy L Bauer; Trachette L Jackson; Yi Jiang
Journal:  Biophys J       Date:  2007-02-02       Impact factor: 4.033

3.  Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH.

Authors:  J J Casciari; S V Sotirchos; R M Sutherland
Journal:  J Cell Physiol       Date:  1992-05       Impact factor: 6.384

Review 4.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

5.  Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model.

Authors:  Paul K Newton; Jeremy Mason; Kelly Bethel; Lyudmila Bazhenova; Jorge Nieva; Larry Norton; Peter Kuhn
Journal:  Cancer Res       Date:  2013-02-27       Impact factor: 12.701

6.  A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype.

Authors:  P Gerlee; A R A Anderson
Journal:  J Theor Biol       Date:  2007-11-04       Impact factor: 2.691

7.  Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature.

Authors:  M W Dewhirst; C Y Tso; R Oliver; C S Gustafson; T W Secomb; J F Gross
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-07       Impact factor: 7.038

Review 8.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

Review 9.  Intratumor heterogeneity: evolution through space and time.

Authors:  Charles Swanton
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

10.  Multiscale modelling of vascular tumour growth in 3D: the roles of domain size and boundary conditions.

Authors:  Holger Perfahl; Helen M Byrne; Tingan Chen; Veronica Estrella; Tomás Alarcón; Alexei Lapin; Robert A Gatenby; Robert J Gillies; Mark C Lloyd; Philip K Maini; Matthias Reuss; Markus R Owen
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

View more
  101 in total

1.  Geostatistical visualization of ecological interactions in tumors.

Authors:  Hunter Bryan Boyce; Parag Mallick
Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)       Date:  2020-02-06

Review 2.  Metabolism and its sequelae in cancer evolution and therapy.

Authors:  Robert J Gillies; Robert A Gatenby
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

Review 3.  Systems Biology of Cancer Metastasis.

Authors:  Yasir Suhail; Margo P Cain; Kiran Vanaja; Paul A Kurywchak; Andre Levchenko; Raghu Kalluri
Journal:  Cell Syst       Date:  2019-08-28       Impact factor: 10.304

4.  Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue.

Authors:  Aleksandra Karolak; Katarzyna A Rejniak
Journal:  Bull Math Biol       Date:  2018-02-08       Impact factor: 1.758

5.  Science and Culture: Putting a game face on biomedical research.

Authors:  Esther Landhuis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-14       Impact factor: 11.205

Review 6.  Tumour acidosis: from the passenger to the driver's seat.

Authors:  Cyril Corbet; Olivier Feron
Journal:  Nat Rev Cancer       Date:  2017-09-15       Impact factor: 60.716

Review 7.  Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment.

Authors:  Mohd Rihan; Lakshmi Vineela Nalla; Anil Dharavath; Amit Shard; Kiran Kalia; Amit Khairnar
Journal:  Cancer Microenviron       Date:  2019-06-10

Review 8.  Homeostasis Back and Forth: An Ecoevolutionary Perspective of Cancer.

Authors:  David Basanta; Alexander R A Anderson
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

Review 9.  Review of quantitative multiscale imaging of breast cancer.

Authors:  Michael A Pinkert; Lonie R Salkowski; Patricia J Keely; Timothy J Hall; Walter F Block; Kevin W Eliceiri
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-22

Review 10.  Pancreatic cancer biology and genetics from an evolutionary perspective.

Authors:  Alvin Makohon-Moore; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Cancer       Date:  2016-07-22       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.